Interleukin-7-Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 12, 2006, Pages 1250-1260

  Sportoletti, Paolo ^a   Del Papa, Beatrice ^a   De Ioanni, Mariangela ^a   Moretti, Lorenzo ^a   Bonifacio, Elisabetta ^a   Lanterna, Vania ^a   Bell, Alain ^a   Fettucciari, Katia ^a   Carnevali, Eugenia ^a   Zei, Tiziana ^a   Falzetti, Franca ^a   Martelli, Massimo F ^a   Tabilio, Antonio ^a   Di Ianni, Mauro ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

CD45RA+; Interleukin 7; Mesenchymal stromal cell; Naive T cell

Indexed keywords

CD3 ANTIGEN; CD45RA ANTIGEN; CD71 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; PHENOTYPE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANTIGENS, CD; APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-7; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RECEPTORS, CHEMOKINE; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; S PHASE; T-LYMPHOCYTE SUBSETS; TRANSDUCTION, GENETIC;

EID: 33845270955     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.09.001     Document Type: Article

References (61)

1. Michie C.A., McLean A., Alcock C., et al. Lifespan of human lymphocyte subsets by CD45 isoforms. Nature 360 (1992) 264-265
2. Fry T.J., and Mackall C.L. Interleukin-7: from bench to clinic. Blood 99 (2002) 3892-3904
3. Peschon J.J., Morrissey P.J., Grabstein K.H., et al. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med 180 (1994) 1955-1960
4. Fry T.J., and Mackall C.L. The many faces of IL-7: from lymphopoiesis to peripheral T-cell maintenance. J Immunol 174 (2005) 6571-6576
5. Von Freeden-Jeffry U., Vieira P., Lucian L.A., et al. Lymphopenia in interleukin (IL-7) gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181 (1995) 1519-1526
6. Puel A., Ziegler S.F., Buckley R.H., et al. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20 (1998) 394-397
7. Tan J.T., Dudl E., Leroy E., et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 98 (2001) 8732-8737
8. Marrack P., and Kappler J. Control of T-cell viability. Annu Rev Immunol 33 (2004) 765-787
9. Kim K., Lee C.K., Sayers T.J., et al. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 160 (1998) 5735-5741
10. Park J.H., Yu Q., Erman B., et al. Suppression of IL7R-alpha transcription by IL-7 and other pro-survival cytokines: a novel mechanism for maximizing IL-7-dependent T-cell survival. Immunity 21 (2004) 289-302
11. + T-cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2 (2001) 415-422
12. Kieper W.C., and Jameson S.C. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA 96 (1999) 13306-13311
13. Schluns K.S., Kieper W.C., Jameson S.C., et al. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1 (2000) 426-432
14. Fry T.J., Connick E., Falloon J., et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 97 (2001) 2983-2990
15. Bhandoola A., Tai X., Eckhaus M., et al. Peripheral expression of self MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T-cell model. Immunity 17 (2002) 425-436
16. Alpdogan O., Schmaltz C., Muriglan S.J., et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggraving graft-versus-host desease. Blood 98 (2001) 2256-2265
17. Sinha M.L., Fry T.J., Fowler D.H., et al. Interleukin-7 worsens graft-versus-host disease. Blood 100 (2002) 2642-2549
18. Smithgall M.D., Wong J.G., Critchett K.E., et al. IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 156 (1996) 2324-2330
19. Broers A.E., Posthumus-Van Slujis S.J., Spits H., et al. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 102 (2003) 1534-1540
20. Levy R.B., Jones M., Hamilton B.L., et al. IL-7 drives donor T-cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation. J Immunol 154 (1995) 106-115
21. Abdul-Hai A., Or R., Slavin S., et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol 24 (1996) 1416-1422
22. Bolotin E., Smogorzewska M., Smith S., et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88 (1996) 1887-1894
23. Alpdogan O., Muriglan S.J., Eng J.M., et al. IL-7 enhances peripheral T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 112 (2003) 1095-1107
24. Mackall C.L., Fry T.J., Bare C., et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97 (2001) 1491-1497
25. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28 (2000) 875-884
26. Bartholomew A., Patil S., Mackay A., et al. Baboon mesenchymal stem cells can be genetically modified to secrete human erytropoietin in vivo. Hum Gene Ther 12 (2001) 1527-1541
27. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
28. Verfaille C.M. Adhesion receptors as regulators of the hematopoieic process. Blood 92 (1998) 2609-2612
29. Majumdar M.K., Thiede M.A., Mosca J.D., et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176 (1998) 57-66
30. Barda-Saad M., Rozenszajn L.A., Globerson A., et al. Selective adhesion of immature thymocytes to bone marrow stromal cells: relevance to T-cell lymphopoiesis. Exp Hematol 24 (1996) 386-391
31. Di Ianni M., Del Papa B., De Ioanni M., et al. Interleukin-7-engineered stromal cells: a new approach for hastening naive T-cell recruitment. Hum Gene Ther 16 (2005) 752-764
32. Wu B.W., Lu J., Gallaher T.K., et al. Identification of regions in the Moloney murine leukemiavirus SU protein that tolerate the insertion of an integrin-binding peptide. Virology 269 (2000) 7-17
33. Di Ianni M., Casciari C., Ciurnelli R., et al. Beta-galactosidase-transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. Haematologica 81 (1996) 410-417
34. Cilloni D., Carlo-Stella C., Falzetti F., et al. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 96 (2000) 3637-3643
35. Steffens C.M., Managlia E.Z., Landay A., et al. Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolated of human immunodeficiency virus 1. Blood 99 (2002) 3310-3318
36. Vermes I., Haanen C., and Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Meth 243 (2000) 167-190
37. Gerashchenko B.I., Azzam E.I., and Howell R.W. Characterization of cell cycle progression and growth of WB-F344 normal rat liver epithelial cells following gamma-ray exposure. Cytometry A 61 (2004) 134-141
38. + T-cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol 161 (1998) 6674-6680
39. Gorsky J., Piatek T., Yassai M., et al. Improvements in repertoire analysis by CDR3 size spectratyping: bifamily PCR. Ann NY Acad Sci 756 (1995) 99-102
40. Wu C.J., Chillemi A., Alyea E.P., et al. Reconstitution of T-cell receptor repertoire diversity following T-cell-depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood 95 (2000) 352-359
41. Di Ianni M., Del Papa B., De Ioanni M., et al. Mesenchymal cells: a vehicle for gene therapy. Blood Cells Mol Dis 33 (2004) 267-270
42. Varmus H. Retroviruses. Science 240 (1988) 1427-1435
43. + T cells enables preservation of a naive repertoire. J Immunol 161 (1998) 5909-5917
44. Cavalieri S., Cazzaniga S., Geuna M., et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 102 (2003) 497-505
45. Scripture-Adams D.D., Brooks D.G., Korin Y.D., et al. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol 76 (2002) 13077-13082
46. + T-cell pool. Immunology 98 (1999) 400-405
47. Rathmell J.C., Farkash E.A., Gao W., et al. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 167 (2001) 6869-6876
48. + T cells. Proc Natl Acad Sci USA 98 (2001) 9277-9282
49. Andre-Schmutz I., Bonhomme D., Yates F., et al. IL-7 effect on immunological reconstitution after HSCT depends on MHC incompatibility. Br J Haematol 126 (2004) 844-851
50. Banwell C.M., Parkington K.M., Jenkinson E.J., et al. Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development. Eur J Immunol 20 (2000) 2125-2129
51. Clarke D., Katoh O., Gibbs R.V., et al. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. Cytokine 7 (1995) 325-330
52. Managlia E.Z., Landay A., and Al-Harthi L. Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells. Immunology 114 (2005) 322-335
53. Verhoeyen E., Dardalhon V., Ducrey-Rundquist O., et al. IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101 (2003) 2167-2174
54. Geginat J., Sallusto F., and Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD(+) T cells. J Exp Med 194 (2001) 1711-1719
55. Surh C.D., and Sprent J. Homeostatic T-cell proliferation: how far can T cells be activated to self-ligands?. J Exp Med 192 (2000) F9-F14
56. Goldrath A.W., Luckey C.J., Park R., et al. The molecular program induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci USA 101 (2004) 16885-16890
57. Goldrath A.W., and Bevan M.J. Selecting and maintaining a diverse T-cell repertoire. Nature 402 (1999) 255-262
58. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., et al. LMO-2 associated clonal T-cell proliferation in two patients after gene therapy for SCID-X1. Science 302 (2003) 415-419
59. Gaspar H.B., Parsley K.L., Howe S., et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364 (2004) 2181-2187
60. Jackson DA, Juranek S, Lipps HJ. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol Ther. In press.
61. Di Ianni M., Terenzi A., Falzetti F., et al. Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice. Cancer Gene Ther 9 (2002) 756-761